Holifya
eDR54Effective DR: 54/100. Below median. Measured by StartupHub.ai. Median 68.Agent50Agent Readiness: 50/100. Top 25%. Measured by StartupHub.ai. Median 41.Italy's first digital clinic for the pharmacologic treatment of obesity using AI and advanced diagnostics.
About
Holifya is a digital health platform that provides end-to-end care for patients undergoing pharmacologic treatment of obesity, particularly with GLP-1/GIP therapies. The company uses a Patient Support Program (PSP) diagnostic-data-driven model with an AI system that integrates up to 3,000 biomarkers, including genetic, blood chemistry, and medical history, combined with behavioral and clinical data. This approach supports a multidisciplinary team of specialist physicians, nutritionists, nurses, and coaches to personalize treatment, improve adherence, and reduce side effects.
Key facts
At-a-glance profile data
- Website
- holifya.com
- Headquarters
- Milan, Italy
- Founded
- 2023
- Employees
- 20
- Total funding
- $2M (Seed)
- Business model
- B2C
Funding rounds
Tech stack
Detected on holifya.com, last scanned 14 Oct 2026. Run your own scan
- Hosting
- Google Cloud
- Email provider
- Google Workspace, SendGrid
Frequently asked
What is Holifya's Effective Domain Rating?
StartupHub's Effective Domain Rating for Holifya is 54 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 19, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Holifya trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Holifya is 52 out of 100, based on site security posture and privacy practices.
How much funding has Holifya raised?
Holifya has raised a total of $2M in funding. The most recent round on record is Seed.
How many employees does Holifya have?
Holifya has approximately 20 people on record.